Roberts Christopher D. 4
4 · Black Diamond Therapeutics, Inc. · Filed Dec 16, 2020
Insider Transaction Report
Form 4
Roberts Christopher D.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-12-15−3,200→ 176,109 totalExercise: $10.86Exp: 2029-09-08→ Common Stock (3,200 underlying) - Exercise/Conversion
Common Stock
2020-12-15$10.86/sh+3,200$34,752→ 3,200 total
Footnotes (1)
- [F1]25% of the shares subject to this option vested and became exercisable on September 3, 2020, with the remainder vesting in 36 equal monthly installments thereafter.